Trial Profile
Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Dec 2011
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary) ; Risperidone
- Indications Mania; Schizophrenia
- Focus Therapeutic Use
- Acronyms UPTAQE
- Sponsors AstraZeneca
- 16 Dec 2011 Actual patient number (387) added as reported by ClinicalTrials.gov.
- 01 May 2009 Actual end date (Dec 2007) added as reported by ClinicalTrials.gov.
- 01 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.